Sativex is indicated as treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS) who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.
Oroeze Spray is a locally acting analgesic and anti-inflammatory treatment for the throat and mouth. It is especially useful for the relief of pain in traumatic conditions such as following tonsillectomy or the use of a naso-gastric tube; dental surgery.
Covonia Sore Throat 0.2%/0.05%w/v Oromucosal Spray Menthol Flavour is indicated for the symptomatic relief of painful, irritated sore throats. It is a sugar free preparation and can be used by diabetics. Additional therapy is required in the event of bacterial infection accompanied by fever.
GW Pharmaceuticals PLC announced that one of three Phase III cancer pain trials of its Sativex (delta-9-tetrahydrocannabinol and cannabidiol) failed...
Covonia Sore Throat Spray is indicated for the symptomatic relief of painful, irritated sore throats. It is a sugar free preparation and can be used by diabetics. Additional therapy is required in the event of bacterial infection accompanied by fever.
GW Pharmaceuticals plc , a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product...
Results of the MOVE2 study showed that one month's treatment with Sativex (delta-9-tetrahydrocannabinol and cannabidiol), from Almirall, reduces moderate to...
GW Pharmaceuticals and Otsuka reported top-line results from the remaining two Phase III trials for the investigational product Sativex (nabiximols)...
For the symptomatic relief of severe sore throats.
For inhibition of the formation of dental plaque. As an aid in the treatment and prevention of gingivitis and in the maintenance of oral hygiene, particularly in situations where tooth brushing cannot be adequately employed (e.g. following oral surgery, in physically or mentally handicapped patients, the terminally ill or immunocompromised patients). Also for use in a post-peridontal surgery or treatment* regimen to promote gingival healing. *NB: Use as part of a post-periodontal treatment regimen has only been adequately studied over the short term and following standard root surface instrumentation. It is useful in the management of aphthous ulceration and oral candidal infections (e.g. denture stomatitis and thrush).